News
STIM
1.770
-1.12%
-0.020
Neuronetics files Form 3 for EVP and Greenbrook GM Cory Anderson
PUBT · 1d ago
Weekly Report: what happened at STIM last week (0706-0710)?
Weekly Report · 1d ago
Weekly Report: what happened at STIM last week (0629-0703)?
Weekly Report · 07/06 09:51
Weekly Report: what happened at STIM last week (0622-0626)?
Weekly Report · 06/29 09:48
Neuronetics Promotes Cory Anderson to Lead Greenbrook Unit
TipRanks · 06/23 22:01
Neuronetics promotes Cory Anderson to EVP, Greenbrook general manager effective July 1
PUBT · 06/23 20:39
Weekly Report: what happened at STIM last week (0615-0619)?
Weekly Report · 06/22 09:54
Weekly Report: what happened at STIM last week (0608-0612)?
Weekly Report · 06/15 09:54
Weekly Report: what happened at STIM last week (0601-0605)?
Weekly Report · 06/08 09:52
Neuronetics names Robert Greene senior vice president of sales
PUBT · 06/02 20:31
NEURONETICS APPOINTS ROBERT GREENE AS SENIOR VICE PRESIDENT SALES
Reuters · 06/02 20:30
Neuronetics spotlights real-world NeuroStar TMS outcomes data at Clinical TMS Society meeting
PUBT · 06/02 12:35
Weekly Report: what happened at STIM last week (0525-0529)?
Weekly Report · 06/01 09:54
Neuronetics Shareholders Approve Directors, Auditor and Equity Plan
TipRanks · 05/29 22:21
Weekly Report: what happened at STIM last week (0518-0522)?
Weekly Report · 05/25 09:57
Neuronetics Extends Interim Financial Leadership Through Amended Agreement
TipRanks · 05/22 11:59
Neuronetics shifts interim finance officer Brown to $26,000 monthly consulting fee
PUBT · 05/22 11:33
Major Investor Quietly Ramps Up Stake in Neuronetics Stock
TipRanks · 05/21 02:02
Neuronetics 10% owner Jorey Chernett buys 100,000 shares for $117,000
PUBT · 05/20 16:40
Weekly Report: what happened at STIM last week (0511-0515)?
Weekly Report · 05/18 09:56
More
Webull provides a variety of real-time STIM stock news. You can receive the latest news about Neuronetics through multiple platforms. This information may help you make smarter investment decisions.
About STIM
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.